Alopecia associated with ritonavir-boosted atazanavir therapy

被引：3
|
作者：
Torres, Harrys A.
Barnetth, Ben J.
Arduino, Roberto C.
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis Infec Control & Employee Hlth, Houston, TX 77030 USA
[2] Univ Texas, Hlth Sci Ctr, Houston Med Sch, Dept Internal Med,Div Infect Dis, Houston, TX USA
来源：
AIDS | 2007年 / 21卷 / 10期
关键词：
D O I：
10.1097/QAD.0b013e3281532b42
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1391 / 1392
页数：2
相关论文
共 50 条
  • [41] Use of Ritonavir-Boosted Nirmatrelvir in Pregnancy
    Siberry, George K.
    Mofenson, Lynne M.
    Calmy, Alexandra
    Reddy, Uma M.
    Abrams, Elaine J.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (12) : 2279 - 2280
  • [42] Chronic interstitial nephritis in an HIV type-1-infected patient receiving ritonavir-boosted atazanavir
    Viglietti, Denis
    Verine, Jerome
    De Castro, Nathalie
    Scemla, Anne
    Daudon, Michel
    Glotz, Denis
    Pillebout, Evangeline
    ANTIVIRAL THERAPY, 2011, 16 (01) : 119 - 121
  • [43] Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes
    Capel, Emilie
    Auclair, Martine
    Caron-Debarle, Martine
    Capeau, Jacqueline
    ANTIVIRAL THERAPY, 2012, 17 (03) : 549 - 556
  • [44] Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
    Conradie, F.
    Zorrilla, C.
    Josipovic, D.
    Botes, M.
    Osiyemi, O.
    Vandeloise, E.
    Eley, T.
    Child, M.
    Bertz, R.
    Hu, W.
    Wirtz, V.
    McGrath, D.
    HIV MEDICINE, 2011, 12 (09) : 570 - 579
  • [45] Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations
    Puligujja, Pavan
    Balkundi, Shantanu S.
    Kendrick, Lindsey M.
    Baldridge, Hannah M.
    Hilaire, James R.
    Bade, Aditya N.
    Dash, Prasanta K.
    Zhang, Gang
    Poluektova, Larisa Y.
    Gorantla, Santhi
    Liu, Xin-Ming
    Ying, Tianlei
    Feng, Yang
    Wang, Yanping
    Dimitrov, Dimiter S.
    McMillan, JoEllyn M.
    Gendelman, Howard E.
    BIOMATERIALS, 2015, 41 : 141 - 150
  • [46] Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
    Montanha, Maiara Camotti
    Fabrega, Francesc
    Howarth, Alice
    Cottura, Nicolas
    Kinvig, Hannah
    Bunglawala, Fazila
    Lloyd, Andrew
    Denti, Paolo
    Waitt, Catriona
    Siccardi, Marco
    CLINICAL PHARMACOKINETICS, 2022, 61 (03) : 375 - 386
  • [47] Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen
    Boffito, M
    Kurowski, M
    Kruse, G
    Hill, A
    Benzie, AA
    Nelson, MR
    Moyle, GJ
    Gazzard, BG
    Pozniak, AL
    AIDS, 2004, 18 (09) : 1291 - 1297
  • [48] Virologic and Immunologic Responses in Treatment-Naive Patients to Ritonavir-Boosted Atazanavir or Efavirenz With a Common Backbone
    Wang, Qing
    Young, Jim
    Bernasconi, Enos
    Vernazza, Pietro
    Calmy, Alexandra
    Cavassini, Matthias
    Furrer, Hansjakob
    Fehr, Jan
    Bucher, Heiner C.
    Battegay, Manuel
    HIV CLINICAL TRIALS, 2014, 15 (03): : 92 - 103
  • [49] Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
    Maiara Camotti Montanha
    Francesc Fabrega
    Alice Howarth
    Nicolas Cottura
    Hannah Kinvig
    Fazila Bunglawala
    Andrew Lloyd
    Paolo Denti
    Catriona Waitt
    Marco Siccardi
    Clinical Pharmacokinetics, 2022, 61 : 1641 - 1641
  • [50] Effects of Ritonavir-Boosted Lopinavir on the Pharmacokinetics of Quinine
    Nyunt, M. M.
    Lu, Y.
    Yu, Q.
    El-Gasim, M.
    Parsons, T. L.
    Petty, B. G.
    Hendrix, C. W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (05) : 889 - 895
12345